Clinical Trials Browser

Interventional × RAD1901 × Breast × Clear all

NCT05386108 2026-02-05

ELECTRA

Phase 1/2 Recruiting

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

NCT07222215 2026-01-22

CAPELA

Phase 2 Recruiting

Breast Neoplasms

NCT05963997 2026-01-16

SUMIT-ELA

Phase 1/2 Active not recruiting

Breast Neoplasms

NCT03778931 2025-09-15

EMERALD

Phase 3 Completed

478 enrolled 16 charts 1 FDA

Breast Neoplasms

NCT05618613 2025-05-09

ELONA

Phase 1/2 Terminated

Breast Neoplasms

NCT06126575 2024-11-19

A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function

Phase 1 Completed

Breast Neoplasms

NCT02650817 2022-08-18

Phase IB Study to Evaluate RAD1901 on the Availability of Estrogen Receptor Binding Sites in Metastatic Breast Cancer

Phase 1 Completed

Breast Neoplasms